Compound class:
Synthetic organic
Comment: Compound 4 is from a series of antimalarial hexahydropyrimidine analogues claimed in UCB Biopharma patent WO2022008639A1 [1].
|
|
compound 4 [WO2022008639A1] has been tagged as relevant to malaria pharmacology and is awaiting detailed curation for the Guide to MALARIA PHARMACOLOGY. |